Ovarian cancer research
Ovarian cancer is the fourth most common cancer in UK women, after breast, bowel and lung cancer. Each year there are nearly 7,000 new cases of ovarian cancer in the UK and the disease claim around 4000 lives.
Cancer Research UK is the biggest supporter of ovarian cancer research in the UK. We fund research on all aspects of the disease, from investigating its molecular causes through to developing better ways to detect and treat it.
We also provide a range of information materials aimed at people affected by cancer. There is an extensive section on ovarian cancer on our CancerHelp UK website.
Below are some highlights of our ovarian cancer research portfolio.
Or find out more on our ovarian cancer briefsheet (PDF download, 100kb)
On this page
Angiogenesis/vasculature
Prof Gordon Jayson
Translational Angiogenesis Laboratory
Christie Hospital NHS Trust, Manchester
New cancer treatments that block blood vessel growth
Prof Jonathan Ledermann
Cancer Research UK and UCL Cancer Trials Centre
University College London, London
Improving treatments for ovarian cancer
Biomarkers
Dr James Brenton
Functional Genomics of Ovarian Cancer
Cambridge Research Institute, Cambridge
Finding new ways to overcome drug resistance in ovarian cancer
Prof Robert Brown
Epigenetics Team
Imperial College London and The Institute of Cancer Research, London
'Epigenetics' and the problem of drug resistance
Prof Hani Gabra
Section of Medicine, Department of Oncology
Imperial College of Science, Technology and Medicine, London
Understanding drug resistance in ovarian cancer
Biomarkers
Prof Ian Jacobs
Department of Gynaecological Oncology
University College London, London
Screening for ovarian cancer
Clinical trials
Prof Frances Balkwill
Institute of Cancer
Barts & The London School of Medicine & Dentistry, London
Developing new treatments for ovarian cancer
Prof Jonathan Ledermann
Cancer Research UK and UCL Cancer Trials Centre
University College London, London
Improving treatments for ovarian cancer
Drug discovery & development
Prof Gordon Jayson
Translational Angiogenesis Laboratory
Christie Hospital NHS Trust, Manchester
New cancer treatments that block blood vessel growth
Prof Stan Kaye
Section of Medicine
The Institute of Cancer Research and the Royal Marsden Hospital, Sutton
Developing new cancer treatments
Drug resistance
Dr James Brenton
Functional Genomics of Ovarian Cancer
Cambridge Research Institute, Cambridge
Finding new ways to overcome drug resistance in ovarian cancer
Prof Robert Brown
Epigenetics Team
Imperial College London and The Institute of Cancer Research, London
'Epigenetics' and the problem of drug resistance
Prof Hani Gabra
Section of Medicine, Department of Oncology
Imperial College of Science, Technology and Medicine, London
Understanding drug resistance in ovarian cancer
Prof Stan Kaye
Section of Medicine
The Institute of Cancer Research and the Royal Marsden Hospital, Sutton
Developing new cancer treatments
Screening
Prof Ian Jacobs
Department of Gynaecological Oncology
University College London, London
Screening for ovarian cancer
Prof Peter Sasieni
Biostatistics and Cancer Epidemiology Group
Wolfson Institute, Barts and The London, Queen Mary's School of Medicine and Dentistry, London
Increase text
Decrease text
Print this page
